Interestingly, high S1P levels have also been found in patients with IBD and asthma (81, 98) and, accordingly, these conditions were attenuated by genetic deletion of the enzyme responsible for its synthesis in rodent models of disease or by pharmacological modulation of the S1P–S1PR axis (98–100). This evidence concerns the gene MBTPS1 and asthma.